SCHEMBL4841836

SCHEMBL4841836

COc1ccc2c(c1)/C(=C/C(=O)c1ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc1)NC(C)(C)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.50
PLAU P00749 1/20 0.50
PLAT P00750 1/20 0.50
RXFP1 Q9HBX9 2/20 0.45
PTPN1 P18031 1/20 0.45
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 2/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
KDR P35968 2/20 0.44
TP53 P04637 1/20 0.43
PTGS1 P23219 1/20 0.43
LMNA P02545 1/20 0.43
RAF1 P04049 2/20 0.42
BRAF P15056 2/20 0.42
MAOB P27338 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841846 1.00 PLG (0.50) PLGPLAUPLATRXFP1PTPN1
SCHEMBL4842225 0.94 RXFP1 (0.49) PLGPLAUPLATRXFP1MAPT
SCHEMBL4842235 0.94 RXFP1 (0.49) PLGPLAUPLATRXFP1MAPT
SCHEMBL4845841 0.93 HDAC3 (0.42) PLGPLAUPLATRXFP1MAPT
SCHEMBL4846828 0.93 TRPV1 (0.46) PLGPLAUPLATRXFP1PTPN1
SCHEMBL4846819 0.93 TRPV1 (0.46) PLGPLAUPLATRXFP1PTPN1
SCHEMBL4837807 0.91 KMT2A (0.51) PLGPLAUPLATMAPTMAPK1
SCHEMBL4837792 0.91 KMT2A (0.51) PLGPLAUPLATMAPTMAPK1
SCHEMBL4841961 0.90 RAB9A (0.49) PTPN1MAPTGAAMAPK1TP53
SCHEMBL4841947 0.90 RAB9A (0.49) PTPN1MAPTGAAMAPK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 PLG 1317/4885PLAU 1618/4885PLAT 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.